UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pharmacokinetic and pharmacodynamic analysis of 5-aza-2'-deoxycytidine (decitabine) in the design of its dose-schedule for cancer therapy

Clinical epigenetics, 2013-02, Vol.5 (1), p.3-3, Article 3

2013

Volltextzugriff (PDF)

Pharmacology of 5-Aza-2′-deoxycytidine (decitabine)

Seminars in hematology, 2005-07, Vol.42 (3 Suppl 2), p.S9-S16

Momparler, Richard L.

2005

Volltextzugriff (PDF)

Epigenetic Modulation of Self-Renewal Capacity of Leukemic Stem Cells and Implications for Chemotherapy

Epigenomes, 2020-03, Vol.4 (1), p.3

2020

Volltextzugriff (PDF)

Enhancement of the Antileukemic Action of the Inhibitors of DNA and Histone Methylation: 5-Aza-2'-Deoxycytidine and 3-Deazaneplanocin-A by Vitamin C

Epigenomes, 2021-03, Vol.5 (2), p.7

2021

Volltextzugriff (PDF)

Epigenetic therapy of non-small cell lung cancer using decitabine (5-aza-2'-deoxycytidine)

Frontiers in oncology, 2013, Vol.3, p.188-188

Momparler, Richard L

2013

Volltextzugriff (PDF)

Importance of dose-schedule of 5-aza-2'-deoxycytidine for epigenetic therapy of cancer

BMC cancer, 2008-05, Vol.8 (1), p.128-128, Article 128

2008

Volltextzugriff (PDF)

A Perspective on the Comparative Antileukemic Activity of 5-Aza-2'-deoxycytidine (Decitabine) and 5-Azacytidine (Vidaza)

Pharmaceuticals, 2012-08, Vol.5 (8), p.875-881

Momparler, Richard L

2012

Volltextzugriff (PDF)

Targeting of cancer stem cells by inhibitors of DNA and histone methylation

Expert opinion on investigational drugs, 2015-08, Vol.24 (8), p.1031-1043

2015

Volltextzugriff (PDF)

Cancer epigenetics

Oncogene, 2003-09, Vol.22 (42), p.6479-6483

Momparler, Richard L

2003

Volltextzugriff (PDF)

Epigenetic Therapy of Cancer With 5-Aza-2′-Deoxycytidine (decitabine)

Seminars in oncology, 2005-10, Vol.32 (5), p.443-451

Momparler, Richard L.

2005

Volltextzugriff (PDF)

Preclinical evaluation of the antineoplastic action of 5-aza-2'-deoxycytidine and different histone deacetylase inhibitors on human Ewing's sarcoma cells

Cancer cell international, 2008-11, Vol.8 (1), p.16-16, Article 16

2008

Volltextzugriff (PDF)

Epigenetic therapy of acute myeloid leukemia using 5-aza-2'-deoxycytidine (decitabine) in combination with inhibitors of histone methylation and deacetylation

Clinical epigenetics, 2014-10, Vol.6 (1), p.19-19, Article 19

2014

Volltextzugriff (PDF)

Optimization of cytarabine (ARA-C) therapy for acute myeloid leukemia

Experimental hematology & oncology, 2013-08, Vol.2 (1), p.20-20, Article 20

Momparler, Richard L

2013

Volltextzugriff (PDF)

Potential of 5-aza-2′-deoxycytidine (Decitabine) a potent inhibitor of DNA methylation for therapy of advanced non-small cell lung cancer

Lung cancer, 2001-12, Vol.34, p.111-115

2001

Volltextzugriff (PDF)

Inhibition of DNA and Histone Methylation by 5-Aza-2'-Deoxycytidine (Decitabine) and 3-Deazaneplanocin-A on Antineoplastic Action and Gene Expression in Myeloid Leukemic Cells

Frontiers in oncology, 2017-02, Vol.7, p.19-19

2017

Volltextzugriff (PDF)

3-Deazauridine enhances the antileukemic action of 5-aza-2′-deoxycytidine and targets drug-resistance due to deficiency in deoxycytidine kinase

Leukemia research, 2011-01, Vol.35 (1), p.110-118

2011

Volltextzugriff (PDF)

Synergistic antileukemic action of a combination of inhibitors of DNA methylation and histone methylation

Leukemia research, 2012-08, Vol.36 (8), p.1049-1054

2012

Volltextzugriff (PDF)

Antineoplastic action of 5-aza-2′-deoxycytidine and phenylbutyrate on human lung carcinoma cells

Anti-cancer drugs, 2002-09, Vol.13 (8), p.869-874

2002

Volltextzugriff (PDF)

Epigenetic action of decitabine (5-aza-2′-deoxycytidine) is more effective against acute myeloid leukemia than cytotoxic action of cytarabine (ARA-C)

Leukemia research, 2013-08, Vol.37 (8), p.980-984

2013

Volltextzugriff (PDF)

Synergistic effect of 5-Aza-2'-deoxycytidine and genistein in combination against leukemia

Oncology research, 2008-01, Vol.17 (5), p.223-230

2008

Volltextzugriff (PDF)

Inhibition of cytidine deaminase by zebularine enhances the antineoplastic action of 5-aza-2'-deoxycytidine

Cancer chemotherapy and pharmacology, 2009-02, Vol.63 (3), p.411-416

2009

Volltextzugriff (PDF)

Effect of histone deacetylase inhibitor LAQ824 on antineoplastic action of 5-Aza-2'-deoxycytidine (decitabine) on human breast carcinoma cells

Cancer chemotherapy and pharmacology, 2006-11, Vol.58 (5), p.618-625

2006

Volltextzugriff (PDF)

Antineoplastic action of 5-aza-2'-deoxycytidine and histone deacetylase inhibitor and their effect on the expression of retinoic acid receptor β and estrogen receptor α genes in breast carcinoma cells

Cancer chemotherapy and pharmacology, 2001-07, Vol.48 (1), p.71-76

2001

Volltextzugriff (PDF)

Antileukemic Activity of Genistein, a Major Isoflavone Present in Soy Products

Journal of natural products (Washington, D.C.), 2008-01, Vol.71 (1), p.3-7

2008

Volltextzugriff (PDF)

Preclinical evaluation of antineoplastic activity of inhibitors of DNA methylation (5-aza-2′-deoxycytidine) and histone deacetylation (trichostatin A, depsipeptide) in combination against myeloid leukemic cells

Leukemia research, 2003-05, Vol.27 (5), p.437-444

2003

Volltextzugriff (PDF)

1 – 25 von 137

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(128)
Mit Volltextzugriff
(125)

Publikationsform

Artikel
(136)
Buchkapitel
(1)

Sprache

Englisch
(137)
Japanisch
(13)

Erscheinungsjahr

n.n

Thema

Science & Technology
(88)
Life Sciences & Biomedicine
(87)
Humans
(66)
Oncology
(62)
Azacitidine - Analogs & Derivatives
(56)
Azacitidine - Pharmacology
(39)
Animals
(37)
Biological And Medical Sciences
(36)
Medical Sciences
(33)
Pharmacology & Pharmacy
(33)
Decitabine
(28)
Pharmacology. Drug Treatments
(28)
Dna Methylation
(27)
Antineoplastic Agents
(26)
Mice
(25)
Chemotherapy
(24)
5-Aza-2′-Deoxycytidine
(23)
Male
(20)
Antimetabolites, Antineoplastic - Pharmacology
(19)
Antineoplastic Agents - Pharmacology
(19)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pharmacokinetic and pharmacodynamic analysis of 5-aza-2'-deoxycytidine (decitabine) in the design of its dose-schedule for cancer therapy

Pharmacology of 5-Aza-2′-deoxycytidine (decitabine)

Epigenetic Modulation of Self-Renewal Capacity of Leukemic Stem Cells and Implications for Chemotherapy

Enhancement of the Antileukemic Action of the Inhibitors of DNA and Histone Methylation: 5-Aza-2'-Deoxycytidine and 3-Deazaneplanocin-A by Vitamin C

Epigenetic therapy of non-small cell lung cancer using decitabine (5-aza-2'-deoxycytidine)

Importance of dose-schedule of 5-aza-2'-deoxycytidine for epigenetic therapy of cancer

A Perspective on the Comparative Antileukemic Activity of 5-Aza-2'-deoxycytidine (Decitabine) and 5-Azacytidine (Vidaza)

Targeting of cancer stem cells by inhibitors of DNA and histone methylation

Cancer epigenetics

Epigenetic Therapy of Cancer With 5-Aza-2′-Deoxycytidine (decitabine)

Preclinical evaluation of the antineoplastic action of 5-aza-2'-deoxycytidine and different histone deacetylase inhibitors on human Ewing's sarcoma cells

Epigenetic therapy of acute myeloid leukemia using 5-aza-2'-deoxycytidine (decitabine) in combination with inhibitors of histone methylation and deacetylation

Optimization of cytarabine (ARA-C) therapy for acute myeloid leukemia

Potential of 5-aza-2′-deoxycytidine (Decitabine) a potent inhibitor of DNA methylation for therapy of advanced non-small cell lung cancer

Inhibition of DNA and Histone Methylation by 5-Aza-2'-Deoxycytidine (Decitabine) and 3-Deazaneplanocin-A on Antineoplastic Action and Gene Expression in Myeloid Leukemic Cells

3-Deazauridine enhances the antileukemic action of 5-aza-2′-deoxycytidine and targets drug-resistance due to deficiency in deoxycytidine kinase

Synergistic antileukemic action of a combination of inhibitors of DNA methylation and histone methylation

Antineoplastic action of 5-aza-2′-deoxycytidine and phenylbutyrate on human lung carcinoma cells

Epigenetic action of decitabine (5-aza-2′-deoxycytidine) is more effective against acute myeloid leukemia than cytotoxic action of cytarabine (ARA-C)

Synergistic effect of 5-Aza-2'-deoxycytidine and genistein in combination against leukemia

Inhibition of cytidine deaminase by zebularine enhances the antineoplastic action of 5-aza-2'-deoxycytidine

Effect of histone deacetylase inhibitor LAQ824 on antineoplastic action of 5-Aza-2'-deoxycytidine (decitabine) on human breast carcinoma cells

Antineoplastic action of 5-aza-2'-deoxycytidine and histone deacetylase inhibitor and their effect on the expression of retinoic acid receptor β and estrogen receptor α genes in breast carcinoma cells

Antileukemic Activity of Genistein, a Major Isoflavone Present in Soy Products

Preclinical evaluation of antineoplastic activity of inhibitors of DNA methylation (5-aza-2′-deoxycytidine) and histone deacetylation (trichostatin A, depsipeptide) in combination against myeloid leukemic cells

Suchergebnisse filtern